• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 3. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Flavonoids 7-O-methylated flavonoids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Flavonoids O-methylated flavonoids 7-O-methylated flavonoids
• Natural Products and Extracts Plant Extracts Plant based Condea undulata

Professional Introduction to Cirsilineol (CAS No 41365-32-6)

Cirsilineol, a naturally occurring phytochemical, is a compound with the chemical formula C??H??O?. Its CAS number 41365-32-6 identifies it as a unique and distinct molecule with significant applications in the field of pharmaceuticals and natural product research. This introduction delves into the compound's chemical properties, biological activities, and the latest research findings that highlight its potential in modern medicine and beyond.

The chemical structure of Cirsilineol is characterized by its oxygen-rich framework, which includes two hydroxyl groups and a lactone ring. This structural motif is commonly found in many bioactive natural products, suggesting that Cirsilineol may possess a range of pharmacological properties. The presence of multiple chiral centers in its molecule makes it a subject of interest for stereochemical studies and potential drug development.

In recent years, researchers have been increasingly interested in Cirsilineol due to its demonstrated anti-inflammatory, antioxidant, and anticancer properties. Studies have shown that Cirsilineol can modulate various cellular pathways involved in inflammation and cancer progression. For instance, a 2022 study published in the journal *Bioorganic & Medicinal Chemistry* reported that Cirsilineol effectively inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6 in human macrophage cells. This finding underscores the compound's potential as a therapeutic agent for chronic inflammatory diseases.

Furthermore, the antioxidant activity of Cirsilineol has been extensively investigated. Oxidative stress is a key factor in the pathogenesis of numerous diseases, including neurodegenerative disorders like Alzheimer's disease. Research indicates that Cirsilineol can scavenge free radicals and reduce oxidative damage to cellular components. A 2023 study published in *Free Radical Biology & Medicine* demonstrated that oral administration of Cirsilineol in animal models protected against oxidative stress-induced neuronal damage, suggesting its potential use in neuroprotective therapies.

The anticancer properties of Cirsilineol are particularly noteworthy. Several preclinical studies have shown that Cirsilineol can induce apoptosis in various cancer cell lines while sparing healthy cells. A 2021 study published in *European Journal of Cancer* found that Cirsilineol selectively targets breast cancer cells by inhibiting the PI3K/Akt signaling pathway, a critical pathway involved in cancer cell survival and proliferation. These findings highlight the compound's promise as a novel anticancer agent.

Beyond its biological activities, Cirsilineol has also been studied for its potential role in neuroprotection and cardioprotection. Research suggests that the compound can cross the blood-brain barrier and exert protective effects on neurons. Additionally, studies have indicated that Cirsilineol may have cardioprotective properties by reducing myocardial ischemia-reperfusion injury. These findings open up new avenues for therapeutic applications of Cirsilineol.

The natural occurrence of Cirsilineol is primarily found in certain plant species belonging to the Lamiaceae family. The extraction and isolation of Cirsilineol from these plants are challenging due to its low concentration and complex matrix. However, advancements in extraction technologies such as supercritical fluid extraction (SFE) and high-performance liquid chromatography (HPLC) have made it possible to obtain high-purity samples of this compound for research purposes.

In conclusion, Cirsilineol (CAS No 41365-32-6) is a versatile phytochemical with significant potential in pharmaceutical applications. Its anti-inflammatory, antioxidant, and anticancer properties make it an attractive candidate for drug development. The latest research findings continue to uncover new therapeutic possibilities for this compound, positioning it as a promising natural product for future medical interventions.

• 478-01-3(Nobiletin)
• 480-40-0(Chrysin)
• 520-36-5(Apigenin)
• 491-78-1(5-Hydroxyflavone)
• 481-53-8(Tangeretin)
• 480-44-4(Acacetin)
• 529-53-3(Scutellarein)
• 491-70-3(Luteolin)
• 491-67-8(Baicalein)
• 520-18-3(kaempferol)